FOXO Technologies Inc.

FOXO

US3514713052

IT Services & Consulting

Market Closed - Nyse Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
0.297 ^USD	-5.35%		+8.75%	-7.10%

Apr. 28	FOXO Technologies Inc. announced that it has received $0.11 million in funding from LGH Investments, LLC	CI
Apr. 24	Sector Update: Tech Stocks Higher Premarket Wednesday	MT

FOXO Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023

January 19, 2024 at 05:05 pm EST

FOXO Technologies Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.01 million compared to USD 0.014 million a year ago. Net loss was USD 3.66 million compared to USD 41.03 million a year ago. Basic loss per share from continuing operations was USD 0.75 compared to USD 67.04 a year ago.
For the nine months, sales was USD 0.035 million compared to USD 0.093 million a year ago. Net loss was USD 22.59 million compared to USD 76.93 million a year ago. Basic loss per share from continuing operations was USD 7.48 compared to USD 128.65 a year ago.

Latest news about FOXO Technologies Inc.

FOXO Technologies Inc. announced that it has received $0.11 million in funding from LGH Investments, LLC	Apr. 27	CI
Sector Update: Tech Stocks Higher Premarket Wednesday	Apr. 24	MT
FOXO Technologies Gets Non-Compliance Notice From NYSE American	Apr. 24	MT
FOXO Technologies Inc. announced that it has received $0.1422 million in funding	Mar. 19	CI
FOXO Technologies Inc. announced that it expects to receive $0.1422 million in funding	Mar. 04	CI
FOXO Technologies Inc. entered into a non-binding agreement to acquire M2i Global, Inc..	Feb. 13	CI
FOXO Technologies Inc. announced that it has received $0.45747 million in funding	Feb. 11	CI
FOXO Technologies Shares Jump After Interim CEO Discloses Stake	Feb. 05	MT
FOXO Technologies Inc. Announces Appointment of Francis Colt Dewolf to the Board of Directors	Jan. 25	CI
Wall Street Set to Open Higher in Monday Trading Ahead of Economic Indicators Data	Jan. 22	MT
FOXO Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Jan. 19	CI
FOXO Technologies Inc. announced that it expects to receive $0.45747 million in funding	Jan. 18	CI
FOXO Technologies Inc. Announces the Resignation of Andrew Poole from the Board of Directors	Nov. 27	CI
FOXO Technologies Inc. Plans to Unveil its New Direct-To-Consumer App, the VITHAR? AI Health Coach	Nov. 08	CI
FOXO Technologies Inc. Unveils Plans for New Direct-To Consumer Offering Combining the Company's Epigenetic Data with the Power of Ai	23-10-30	CI
North American Morning Briefing : Rate Decisions, Jobs Data Headline a Busy Week	23-10-30	DJ
FOXO Technologies Completes Strategic Alternatives Review	23-10-22	CI
FOXO Technologies Inc. Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers	23-10-13	CI
FOXO Technologies Inc. Appoints Martin Ward as Interim Chief Financial Officer	23-09-19	CI
FOXO Technologies Inc. Announces CEO Changes	23-09-19	CI
FOXO Technologies Inc. Announces Executive Changes	23-09-19	CI
FOXO Technologies Inc. announced that it has received $0.7435 million in funding	23-09-11	CI
FOXO Technologies Inc. announced that it has received $0.2935 million in funding	23-09-06	CI
FOXO Technologies Inc. announced that it expects to receive $0.2935 million in funding	23-08-22	CI
Earnings Flash (FOXO) FOXO TECHNOLOGIES Reports Q2 Revenue $12,000	23-08-10	MT

Chart FOXO Technologies Inc.

Duration

Period

More charts

Company Profile

FOXO Technologies Inc. is a biotechnology company. The Company is focused on commercializing longevity science through products and services that serve the life insurance industry. Its epigenetic technology applies artificial intelligence (AI) to deoxyribonucleic acid (DNA) methylation to identify molecular biomarkers of human health and aging. The Company operates through two segments: FOXO Labs and FOXO Life. FOXO Labs is commercializing epigenetic biomarker technology to be used for mortality underwriting and risk classification in the global life insurance industry. Its biomarker technology enables the adoption of new saliva-based health and wellness biomarker solutions for underwriting and risk assessment. FOXO Life is redefining the relationship between consumers and insurers by combining life insurance with healthy longevity. FOXO Life seeks to transform the value proposition of the life insurance carrier from a provider of mortality risk protection products.

Sector

IT Services & Consulting

Calendar

2024-11-10 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other IT Services & Consulting

	1st Jan change	Capi.
FOXO TECHNOLOGIES INC.	-7.10%	3M
ACCENTURE PLC	-13.48%	191B
TATA CONSULTANCY SERVICES LTD.	+1.53%	167B
IBM	+3.37%	155B
AUTOMATIC DATA PROCESSING, INC.	+8.31%	103B
CROWDSTRIKE HOLDINGS, INC.	+35.49%	83.67B
RELX PLC	+11.19%	82.06B
INFOSYS LIMITED	-6.43%	71.79B
SNOWFLAKE INC.	-18.66%	54.05B
HCL TECHNOLOGIES LIMITED	-8.68%	43.34B

Other IT Services & Consulting